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Influenza viruses are a continuous threat to humans because of their
ability to cross species barriers and adapt to new hosts. Data from
murine studies, along with limited human data, suggest that CD8+
cytotoxic T lymphocytes (CTL) that recognize conserved epitopes of
structural influenza proteins are the main mediators of influenza
virus clearance. Additionally, the fact that many CTLs recognize
epitopes shared between different influenza strains offers the
potential for broad cross-strain immunity. However, the
mechanisms of cellular immunity against influenza viruses are
poorly defined in humans, where the CTL response has been hard to
measure and interpret. We developed a novel CTL assay that utilizes
fully differentiated nasal human epithelial cells taken from

volunteers as permissive targets for autologous peripheral bloodderived influenza virus-specific cytotoxic T lymphocytes. This
in vitro system of human lymphocyte–epithelial cell co-cultures can
be considered as the closest approximation to events in vivo and can
be employed for studying the interactions between the pathogen and
human host. Modeling of the natural interaction process between
the primary cell type that supports the productive replication of
influenza and immune cells may allow us to put in perspective CTLs
as a correlate of immunity to influenza in humans.
Keywords Cytotoxic T lymphocytes, influenza virus, lysis, nasal
human epithelial cells.
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Introduction
Influenza viruses are a continuous threat to humans because
of their ability to cross species barriers and adapt to new
hosts. It has been estimated that 5–15% of the world
population are infected during annual outbreaks and that
these infections result in one million deaths every year.1
Influenza virions infect the cells of respiratory pseudostratified columnar epithelium consisting of a single layer of three
major cells types, namely ciliated, goblet, and Clara cells.2
Data from murine studies, along with limited human data,
suggest that CD8+ cytotoxic T lymphocytes (CTL) that
recognize conserved epitopes of structural influenza proteins
are the main mediators of influenza virus clearance.3–7
Additionally, the fact that many CTLs recognize epitopes
shared between different influenza strains offers the potential
for broad cross-strain immunity.8–10 However, the mechanisms of cellular immunity against influenza viruses are
poorly defined in humans, where the CTL response has been
hard to measure and interpret.4,8,9,11 In the present study, we
developed a novel CTL assay that utilizes fully differentiated
nasal human epithelial (NHE) cells taken from volunteers as
permissive targets for autologous peripheral blood-derived
influenza virus-specific cytotoxic T lymphocytes. This in vitro
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system of human lymphocyte–epithelial cell co-cultures can
be considered as the closest approximation to events in vivo
and can be employed for studying the interactions between
the pathogen and human host.

Methods
Cells and viruses
Madin–Darby canine kidney (MDCK) cells were obtained
from the American Type Culture Collection and maintained
as previously described.12 Nasal epithelial (obtained by nasal
swabbing) and peripheral blood mononuclear cells (PBMCs)
were obtained from healthy adult volunteers. Informed
consent was obtained from all volunteers using protocols and
consent forms approved by the Geisel School of Medicine
investigational review board (Dartmouth College). A total of
four participants (three men and one woman, average age
~59 years) were enrolled in the study. All donors were
seropositive to A/California/07/09 (H1N1) virus (mean
hemagglutination inhibition titer ~1/32).
Primary NHE cells of passage 2 were grown either in tissue
culture flasks (i.e., non-differentiated cells) or on membrane
supports (65-mm Transwell; Corning Inc., Corning, NY,
USA) at the air–liquid interface in hormone- and growth
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factor-supplemented serum-free medium and fully differentiated 4- to 8-week-old cultures (~104 cells/insert) were used
for the experiments.13 PBMCs were cryopreserved after
separation on a Ficoll–Hypaque gradient (Sigma-Aldrich, St.
Louis, MO, USA).
The influenza viruses, A/California/07/09 (H1N1) and
A/equine/Tennessee/5/86 (H3N8), were obtained from the
World Health Organization’s collaborating laboratories.

Statistical analysis

Assessment of influenza viral growth

We first assayed whether PBMCs can function as effector
cells. We infected differentiated NHE cells with A/California/
07/09 (H1N1) virus at a multiplicity of infection (MOI) of
001, and autologous PBMCs (E/T  100:1) were added
either to the basal compartment or to the apical side of the
epithelial cells. H1N1 virus replicated to the similar extent at
24 hpi in all the wells, including those that were incubated
without PBMCs (data not shown). We next stimulated
PBMCs for 6 days with the autologous non-differentiated
epithelial cells that had been pre-fixed 24 h after initiation of
infection with the A/California/07/09 strain. No changes in
viral titers were observed between NHE cells incubated in the
presence or absence of the stimulated PBMCs at 24 hpi (data
not shown).
We next examined whether T lymphocytes isolated from
PBMCs could be used as effector cells by comparing viral
titers in H1N1-infected epithelial cells in the presence of
stimulated versus unstimulated T cells. Viral titers measured
at 24 and 48 hpi were statistically significantly reduced after
addition of autologous stimulated T lymphocytes compared
with the control NHE cells infected with the A/California/07/
09 virus (P < 005). In contrast, incubation with the
unstimulated T cells had no effect on viral replication in
the H1N1-infected NHEs (Figure 1A). We also observed that
proliferation of stimulated T lymphocytes was significantly
greater than that of unstimulated T cells at 24 and 48 hpi
(P < 005), indicating that the absence of decreased viral
growth after 72 h incubation with stimulated T cells was
likely due to a loss of T-cell viability (Figure 1B).
We next tested whether the reduction of viral titers by the
stimulated T lymphocytes was influenza subtype-specific in
the infected epithelial cells. NHEs were infected with the
A/California/07/09 and A/equine/Tennessee/5/86 (H3N8)
strains, and the use of these cells as stimulators was
compared (Figure 2). Our data showed that despite the fact
that the H3N8 virus was able to infect NHE cells,15 these
cultures were not very effective in stimulating a secondary
CTL response (P ˃ 005). However, some non-specific lysis
that was not associated with the reduced viral titers in the
target NHEs was seen when high concentrations of the
effector T cells (i.e., E/T  220:1) stimulated with the H3N8infected nasal cells were added. We also observed that the
H1N1-pulsed T lymphocytes isolated from the same individual can function as stimulator population, as indicated by

Infectivity and viral yields were determined in MDCK cells by
plaque assay and by 50% tissue culture infectious dose
(TCID50) assay as described previously.12 Briefly, confluent
MDCK cells were incubated at 37°C for 1 h with 10-fold
serial dilutions of virus. The cells were then washed and
overlaid with minimal essential medium containing 03%
bovine serum albumin and 09% Bacto agar and incubated at
37°C for 72 h. Plaques were stained with 01% crystal violet
solution containing 10% formaldehyde, and virus yield was
expressed as log10 plaque-forming units (PFU)/ml. In the
TCID50 assay, confluent monolayers of cell cultures growing
in 96-well microplates were inoculated with serial virus
dilutions in the presence of trypsin. After 3 days, virus was
titrated by hemagglutination assay, and virus titers were
expressed as log10TCID50/ml by the endpoint method of
Reed and Muench.12,14

Cytotoxicity assay
T lymphocytes (CD4+ and CD8+) were generated from
PBMCs using human T-cell enrichment RosetteSep kit
(STEMCELL Technologies Inc., Vancouver, BC, Canada).
Stimulation of lymphocytes was carried out in 6-well plates
using autologous non-differentiated NHE cells infected with
influenza A viruses. One day after initiation of infection, the
stimulator cells were fixed and lymphocytes were added for
secondary stimulation. Additionally, autologous T lymphocytes pulsed for 2 h with influenza viruses were also used as
stimulator populations. Human rIL-2 was added on day 3 and
the total stimulation interval was 6 days, after which the
stimulated lymphocytes were washed and used in a colorimetric cytotoxicity assay (LDH; Roche, Palo Alto, CA, USA).
In brief, NHE cultures seeded on Transwell membranes were
infected by exposure of the apical side with influenza viruses,
and the stimulated lymphocytes were added 2 h post-infection
(hpi) as effector cells, at effector-to-target (E/T) ratios ranging
from 220:1 to 10:1, and incubated for 6 h. Lactate dehydrogenase, which is released from the cytosol of damaged cells,
was measured on a Molecular Devices multilabel reader with a
490-nm filter (Molecular Devices Inc., Sunnyvale, CA, USA).
Cell viability of stimulated and unstimulated T lymphocytes in co-culture with H1N1-infected epithelial cells was
measured using CellTiter Aqueous One solution (Promega,
Madison, WI, USA).

The levels of viral titers, T-cell proliferation, and specific lysis
were compared by unpaired t-test or analysis of variance
(ANOVA). A probability value of 005 was prospectively chosen
to indicate that the findings of these analyses were not the
result of chance alone.

Results
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Figure 1. (A) Reduction of viral titers in differentiated nasal epithelial
cells infected with A/California/07/09 virus (MOI = 001) after
addition of autologous stimulated and unstimulated T lymphocytes
(E/T ratio  25:1). The T cells were added 2 hpi and were incubated with
the nasal human epithelial (NHE) cells for the indicated time intervals.
*, P < 005 compared with control NHEs that were incubated in the
absence of effector T cells (one-way ANOVA). (B) Mean proliferation of
stimulated and unstimulated T lymphocytes measured by a 3-(4,5dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium, inner salt (MTS)-based assay. The T cells were added 2 hpi
and were incubated with the H1N1-infected NHE cells. The T lymphocytes
were collected, and their viability was measured at the indicated time
intervals. *, P < 005 compared with the value for unstimulated T cells by
an unpaired t-test.

the secondary CTL response and reduction of viral titers in
the autologous NHEs (Figure 2). No specific lysis was
detected when heterologous target cells were used (data not
shown), suggesting that the CTL response was human
leukocyte antigen-restricted. Additionally, we assayed
whether non-differentiated nasal epithelial cells could be
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Figure 2. LDH assay based on non-differentiated nasal epithelial and T
cells as stimulators, T lymphocytes as effectors, and infected differentiated
nasal human epithelial (NHE) cells as targets. Stimulator cells were
incubated with either A/California/07/09 or A/equine/Tennessee/5/86
(H3N8) viruses (MOI = 5), and target cells were infected with A/California/
07/09 virus (MOI = 001). All cells were isolated from the same adult
individual. Cytotoxic T lymphocytes (CTL) response was measured 6 h
after the effectors cells were added to the target cells. Arrows and
corresponding numbers indicate the statistically significant reduction of
viral titers in the target cells at 24 hpi as determined by plaque assay
(P < 005).

used as the target cells. Our results demonstrated that
although the specificity of autologous stimulated T lymphocytes has not been tested, they were able to significantly
reduce virus titers at all time points tested (˃15 logs,
P < 005; Figure 3).

Discussion
Despite the fact that the CTL response has a wellcharacterized role in protection and in recovery from
influenza virus infection in the murine model,3,16 such a
role has not been well documented for humans.11 Determination of CTL responses in humans by traditional assays
has been restricted by the large volumes of blood needed
and the non-permissivity of the stimulator and target cells
used for the assays. Previously, investigations of cellmediated immunologic responses to influenza virus have
employed either lymphoproliferative responses of peripheral
blood lymphocytes, chromium release assay, or IFN-c flow
cytometric assay/ELISpots.8,17,18 However, these assays have
not always correlated with serum antibody titers to
influenza virus and have limited sensitivity.8,18 Furthermore,
there is an uncertainty in interpreting the significance of
CTL responses measured by these assays because they are
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immunotherapeutic approaches that will improve both
antiviral T-cell responses and viral clearance.
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Figure 3. Reduction of viral titers in non-differentiated nasal epithelial
cells infected with A/California/07/09 virus (MOI = 001) after addition of
autologous stimulated T lymphocytes at indicated E/T ratio. The T cells
were added 2 hpi and were incubated with the nasal human epithelial
(NHE) cells for the indicated time intervals. *, P < 005 compared with the
control NHEs that were incubated in the absence of the effector T cells
(one-way ANOVA).

often measures of T-cell activation, but not of effector
function. To understand the significance of CTL responses
in humans, we must utilize optimal model systems. Here,
we developed the novel concept of using differentiated NHE
cells as natural and permissive targets for influenza virus
cytotoxic T lymphocytes in a CTL assay. This human cellculture-based system of autologous stimulated lymphocyte–
epithelial cell co-cultures provides a valuable tool for the
measurement of the levels of CTL immunity as potential
protective cell-mediated immunity at the mucosal level in
humans.
Our results suggest that cytotoxic T cells play a role in
recovery from influenza infection in humans and that nasal
airway epithelia have the capacity to perform as accessory
cells in vitro. We speculate that NHE cells as the primary cell
type infected with influenza A viruses2 may function to
encounter influenza antigen and directly interact with T cells
to initiate local mucosal immune responses. Our data are
consistent with the fact that normal human lungs also
contain large numbers of resident memory T cells, and these
cells are poised to respond to recall antigens previously
encountered through lung mucosa.19 Overall, we believe that
modeling of the natural interaction process between the
primary cell type that supports the productive replication of
influenza and immune cells can provide critical information
about complex networks established between these cells and,
therefore, will allow us to put in perspective CTLs as a
correlate of immunity to influenza in humans. Understanding the mechanisms by which the inflammatory milieu is
created in human conducting airways during influenza
disease is likely to lead to the development of
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